Fate Therapeutics Inc. (FATE)
Market Closed
16 Oct, 08:00 PM
$
1. 79
-0.14
-7.2539%
$
254.1M Market Cap
- P/E Ratio
- Div Yield
1.38M Volume
-1.96 Eps
$ 1.93
Previous Close 
Want to track FATE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fate Therapeutics Inc. (FATE) Statistics
Valuation metrics
Market Cap 254.1M
Enterprise value 297.34M
Trailing P/E (ttm) -2.08
Forward P/E -
PEG ratio -0.06
Price/Sales (ttm) 39.15
Price/Book (mrq) 1.71
Enterprise Value/Revenue 45.81
Enterprise Value/EBITDA -2.6
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 770.7K
Average volume (90 days) 1.6M
Price summary
52-Week low 0.95
52-Week high 3.23
Beta -
50-Day moving average 2.38
200-Day moving average 1.83
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -19.41%
Operating margin -20.58%
Operational effectiveness
Return on assets -0.48%
Return on equity -0.65%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.28
Total debt (mrq) -
Total Debt/Equity (mrq) 0.49
Current ratio (mrq) 4.85%
Book value per share (mrq) 1.27
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
